BR112012007301B8 - complexo de associação intermolecular de um transportador anfifílico e de um princípio ativo, seu uso e processo de preparação, bem como composição farmacêutica que o compreende - Google Patents

complexo de associação intermolecular de um transportador anfifílico e de um princípio ativo, seu uso e processo de preparação, bem como composição farmacêutica que o compreende

Info

Publication number
BR112012007301B8
BR112012007301B8 BR112012007301A BR112012007301A BR112012007301B8 BR 112012007301 B8 BR112012007301 B8 BR 112012007301B8 BR 112012007301 A BR112012007301 A BR 112012007301A BR 112012007301 A BR112012007301 A BR 112012007301A BR 112012007301 B8 BR112012007301 B8 BR 112012007301B8
Authority
BR
Brazil
Prior art keywords
well
preparation process
active principle
pharmaceutical composition
association complex
Prior art date
Application number
BR112012007301A
Other languages
English (en)
Other versions
BR112012007301B1 (pt
BR112012007301A2 (pt
Inventor
Bize Cécile
Perez Emile
Rico-Lattes Isabelle
Blanzat Muriel
Original Assignee
Centre Nat Rech Scient
Univ Toulouse 3 Paul Sabatier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Toulouse 3 Paul Sabatier filed Critical Centre Nat Rech Scient
Publication of BR112012007301A2 publication Critical patent/BR112012007301A2/pt
Publication of BR112012007301B1 publication Critical patent/BR112012007301B1/pt
Publication of BR112012007301B8 publication Critical patent/BR112012007301B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

''transporte cooperativo de princípios ativos básicos por moléculas anfífilas''. a presente invenção se refere a um complexo de associação intermolecular de um transportador anfífilo e de um princípio ativo g de fórmula geral (i) a seguir: assim como as composições que o contêm, suas utilizações, notadamente a título de medicamento, e o respectivo processo de preparo.
BR112012007301A 2009-10-02 2010-10-04 complexo de associação intermolecular de um transportador anfifílico e de um princípio ativo, seu uso e processo de preparação, bem como composição farmacêutica que o compreende BR112012007301B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0956893A FR2950902B1 (fr) 2009-10-02 2009-10-02 Transport cooperatif de principes actifs basiques par des molecules amphiphiles acides
FR0956893 2009-10-02
PCT/EP2010/064756 WO2011039379A1 (fr) 2009-10-02 2010-10-04 Transport cooperatif de principes actifs basiques par des molecules amphiphiles acides

Publications (3)

Publication Number Publication Date
BR112012007301A2 BR112012007301A2 (pt) 2016-04-19
BR112012007301B1 BR112012007301B1 (pt) 2021-04-20
BR112012007301B8 true BR112012007301B8 (pt) 2021-05-25

Family

ID=42184153

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012007301A BR112012007301B8 (pt) 2009-10-02 2010-10-04 complexo de associação intermolecular de um transportador anfifílico e de um princípio ativo, seu uso e processo de preparação, bem como composição farmacêutica que o compreende

Country Status (7)

Country Link
US (1) US8895518B2 (pt)
EP (1) EP2482853B1 (pt)
JP (1) JP5913105B2 (pt)
BR (1) BR112012007301B8 (pt)
CA (1) CA2776198C (pt)
FR (1) FR2950902B1 (pt)
WO (1) WO2011039379A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3019039B1 (fr) 2014-03-28 2017-06-02 Affichem Composition cosmetique et/ou dermatologique pour la coloration de la peau
JP7285040B2 (ja) * 2018-06-08 2023-06-01 シオノギヘルスケア株式会社 光安定性を向上させた固形状組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727110B1 (fr) * 1994-11-17 1997-01-17 Stepan Europe Composes amphiphiles mixtes

Also Published As

Publication number Publication date
JP2013506642A (ja) 2013-02-28
US20120214756A1 (en) 2012-08-23
CA2776198C (fr) 2018-08-28
JP5913105B2 (ja) 2016-04-27
FR2950902B1 (fr) 2012-03-30
EP2482853A1 (fr) 2012-08-08
BR112012007301B1 (pt) 2021-04-20
FR2950902A1 (fr) 2011-04-08
WO2011039379A1 (fr) 2011-04-07
US8895518B2 (en) 2014-11-25
CA2776198A1 (fr) 2011-04-07
EP2482853B1 (fr) 2018-11-14
BR112012007301A2 (pt) 2016-04-19

Similar Documents

Publication Publication Date Title
CO6470845A2 (es) Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales
NI201000199A (es) Derivados de indazol sustituidos con fenilo y benzodioxinilo.
BRPI0915064B8 (pt) derivados de quinoxalinadiona, seus usos, e medicamentos
UY31183A1 (es) Derivados de pirazinona y procesos para su preparación
BR112014000713A2 (pt) derivados de indol substituído como moduladores de gama secretase
UY30824A1 (es) Nuevos derivados de idazolil éster o amida, composiciones farmacéuticas conteniéndolas, procesos de preparacion y aplicaciones.
BR122017015106B8 (pt) estrutura de cristal de formula 1b e composição farmacêutica
BRPI0918750B8 (pt) derivado de 2-carboxamida cicloamino ureia, seu uso e sua composição farmacêutica
BR112013000254A2 (pt) derivados heterocíclicos 1-fenil-substituídos e seu uso como moduladores do receptor de prostaglandina d2
CR20120264A (es) Compuestos
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
UY32673A (es) Nuevas pirimidinas, composiciones farmaceuticas que las contienen, procedimientos de preparaciones y su aplicacion como medicamentos
BR112015009603A2 (pt) novos derivados de pirazina
BR112014006248A2 (pt) compostos de triazolopiridina como inibidores de pde10a
BR112014002958A2 (pt) "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com piperidinila antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso".
BR112012030482A2 (pt) tratamento de diabetes tipo 2
BR112012009310A2 (pt) composto, e, composição farmacêutica
BR112014010047A2 (pt) novos derivados de pirazina
BR112014003063A2 (pt) "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com ciclopenta[c]pirrol antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso".
ECSP109961A (es) Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica
BR112014004522A2 (pt) moduladores de pde10
BRPI1008855B8 (pt) derivados de indol, seu uso como agentes anticâncer, seu processo para preparação e composição farmacêutica que os compreende
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
BR112014026817A2 (pt) derivados do pantotenato para o tratamento de transtornos neurológicos
BRPI0908569B8 (pt) estimuladores de secreção de insulina derivados de piridopirazinonas, seu uso, e composição farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/00 (2006.01), A61K 31/5415 (2006.01), A61K

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/10/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/10/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2690 DE 26-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.